FDA orphan drug designation: treatment of congenital adrenal hyperplasia (CAH)
All entries for: Crinetics Pharmaceuticals Inc.
August 18, 2025
Crinetics Pharmaceuticals Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of congenital adrenal hyperplasia (CAH)
